NZ329959A - Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces - Google Patents

Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces

Info

Publication number
NZ329959A
NZ329959A NZ329959A NZ32995995A NZ329959A NZ 329959 A NZ329959 A NZ 329959A NZ 329959 A NZ329959 A NZ 329959A NZ 32995995 A NZ32995995 A NZ 32995995A NZ 329959 A NZ329959 A NZ 329959A
Authority
NZ
New Zealand
Prior art keywords
provoking
cytolytic
treatment
cell response
mhc molecule
Prior art date
Application number
NZ329959A
Inventor
Thomas Woelfel
Pel Aline Van
Vincent Brichard
Thierry Boon-Falleur
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/203,054 external-priority patent/US5530096A/en
Priority claimed from US08/233,305 external-priority patent/US5519117A/en
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Publication of NZ329959A publication Critical patent/NZ329959A/en

Links

NZ329959A 1994-02-28 1995-02-16 Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces NZ329959A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/203,054 US5530096A (en) 1992-12-22 1994-02-28 Isolated, tyrosinase derived peptides and uses thereof
US08/233,305 US5519117A (en) 1992-12-22 1994-04-26 Isolated, tyrosinase derived peptides and uses thereof
NZ282528A NZ282528A (en) 1994-02-28 1995-02-16 Identifying complexes of mhc (esp hla) molecules and tyrosinase derived peptides on abnormal cell surfaces

Publications (1)

Publication Number Publication Date
NZ329959A true NZ329959A (en) 1999-10-28

Family

ID=27353770

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ329959A NZ329959A (en) 1994-02-28 1995-02-16 Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces

Country Status (1)

Country Link
NZ (1) NZ329959A (en)

Similar Documents

Publication Publication Date Title
AU3212689A (en) Medical material permitting cells to enter thereinto and artificial skin
IL115261A0 (en) Three-dimensional human cell cultures on cardiac valve frameworks and their uses
AU1834197A (en) Cells expressing both human cd4 and cxcr4
ZA955621B (en) Cosmetic compositions with keratolytic and anti-acne activity
DE69519547D1 (en) Reformer and fuel cell system using this
AU4348389A (en) Solar electric conversion unit and system
EP0795007A4 (en) Bioengineered human blood cells
AU2766989A (en) Improvements in and relating to sealing and trimming strips
GB2306814B (en) Improvements in or relating to rf power amplifiers
IL98269A0 (en) Lyophilized red blood cell compositions and processes and medium for the lyophilization of cells
AU8021891A (en) Application of liposomic vectors to transport active molecules across the cell membrane and their use in dermatology and in cosmetics
NZ305571A (en) Cryptophycin derivatives, use in pharmaceutical compositions to inhibit mammalian cell proloferation and treat neoplasia
EP0959889A4 (en) Methods and compositions to inhibit keratinocyte proliferation
GB2282188B (en) Improvements in and relating to the generation of electricity
EP0510063A4 (en) Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues
AU3212589A (en) Medical material permitting cells to enter thereinto and artificial skin
NZ329959A (en) Treatment of human cellular abnormality by provoking cytolytic t cell response to cells presenting complexes of an mhc molecule and a tyrosinase derived peptide on their surfaces
AU2087799A (en) Diagnostic and therapeutic methods based upon valpha24jalphaq t cells
AU1524095A (en) Ex vivo activation of immune cells
AU4517289A (en) Trialkylsilyl esters of amino acids and their use in the synthesis of peptides
AU2267892A (en) Molecular encapsulation and delivery of alkanes to living mammalian cells for risk assessment and pharmaceutical application
AUPM598394A0 (en) Transformed human hepatoma cell line which releases insulin
GB9523497D0 (en) Cell membrane protein and application thereof
AU2424897A (en) Human epithelial cell matrix and uses therefor
AU4588189A (en) Imidazole-containing peptide and preparation thereof

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)